102 related articles for article (PubMed ID: 38836854)
1. Comparative Trends in the Distribution of Prostate Cancer Stage at Diagnosis in the Department of Defense Cancer Registry and the Surveillance, Epidemiology, and End Results Data, 2004-2014.
Bandi LL; Lin J; Shriver CD; Chesnut GT; Zhu K
Mil Med; 2024 Jun; ():. PubMed ID: 38836854
[TBL] [Abstract][Full Text] [Related]
2. Comparative Trends in the Distribution of Lung Cancer Stage at Diagnosis in the Department of Defense Cancer Registry and the Surveillance, Epidemiology, and End Results data, 1989-2012.
Nations JA; Brown DW; Shao S; Shriver CD; Zhu K
Mil Med; 2020 Dec; 185(11-12):e2044-e2048. PubMed ID: 32857164
[TBL] [Abstract][Full Text] [Related]
3. Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population.
Lin J; Nousome D; Jiang J; Chesnut GT; Shriver CD; Zhu K
Br J Cancer; 2023 Apr; 128(6):1070-1076. PubMed ID: 36609596
[TBL] [Abstract][Full Text] [Related]
4. Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry.
Flanary JT; Lin J; Shriver CD; Zhu K
Cancer Med; 2023 Nov; 12(22):20989-21000. PubMed ID: 37902129
[TBL] [Abstract][Full Text] [Related]
5. Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
Lin J; Hu H; Shriver CD; Zhu K
Clin Breast Cancer; 2022 Jun; 22(4):e506-e516. PubMed ID: 34961733
[TBL] [Abstract][Full Text] [Related]
6. Differences in Survival between Black and White Patients with Head and Neck Squamous Cell Carcinoma: Comparison of Data from the DOD Central Cancer Registry and SEER.
Lin J; Orestes MI; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2024 Mar; 33(3):426-434. PubMed ID: 38099827
[TBL] [Abstract][Full Text] [Related]
7. Incidence of papillary thyroid cancer: Comparison of the military and the general population by race and tumor stage/size.
Bytnar JA; Enewold L; Shriver CD; Zhu K
Cancer Epidemiol; 2024 Apr; 89():102539. PubMed ID: 38340498
[TBL] [Abstract][Full Text] [Related]
8. Survival among lung cancer patients: comparison of the U.S. military health system and the surveillance, epidemiology, and end results (SEER) program by health insurance status.
Lin J; Shriver CD; Zhu K
Cancer Causes Control; 2024 Jan; 35(1):21-31. PubMed ID: 37532916
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Survival among Colon Cancer Patients in the U.S. Military Health System and Patients in the Surveillance, Epidemiology, and End Results (SEER) Program.
Lin J; McGlynn KA; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1359-1365. PubMed ID: 34162655
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of survival among small cell lung cancer patients in the U.S. military health system and those in the surveillance, epidemiology, and end results (SEER) program.
Lin J; Kamamia C; Brown DW; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
Ann Epidemiol; 2021 Dec; 64():132-139. PubMed ID: 34547444
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.
Henley SJ; King JB; German RR; Richardson LC; Plescia M;
MMWR Surveill Summ; 2010 Nov; 59(9):1-25. PubMed ID: 21102407
[TBL] [Abstract][Full Text] [Related]
12. Survival among patients with glioma in the US Military Health System: A comparison with patients in the Surveillance, Epidemiology, and End Results program.
Lin J; Bytnar JA; Theeler BJ; McGlynn KA; Shriver CD; Zhu K
Cancer; 2020 Jul; 126(13):3053-3060. PubMed ID: 32286688
[TBL] [Abstract][Full Text] [Related]
13. Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population.
Lin J; Kamamia C; Brown D; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):673-679. PubMed ID: 29531129
[No Abstract] [Full Text] [Related]
14. Lung cancer survival among black and white patients in an equal access health system.
Zheng L; Enewold L; Zahm SH; Shriver CD; Zhou J; Marrogi A; McGlynn KA; Zhu K
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1841-7. PubMed ID: 22899731
[TBL] [Abstract][Full Text] [Related]
15. Cancer incidence in the US military: An updated analysis.
Bytnar JA; McGlynn KA; Nealeigh MD; Shriver CD; Zhu K
Cancer; 2024 Jan; 130(1):96-106. PubMed ID: 37725334
[TBL] [Abstract][Full Text] [Related]
16. Trends in Incidence of Metastatic Prostate Cancer in the US.
Desai MM; Cacciamani GE; Gill K; Zhang J; Liu L; Abreu A; Gill IS
JAMA Netw Open; 2022 Mar; 5(3):e222246. PubMed ID: 35285916
[TBL] [Abstract][Full Text] [Related]
17. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
[TBL] [Abstract][Full Text] [Related]
19. Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?
Malik AT; Alexander J; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2021 Mar; 479(3):493-502. PubMed ID: 32805094
[TBL] [Abstract][Full Text] [Related]
20. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
